Drug Trial Radar · NCT07685769
A Study to Find Out if the Medicine Called Rimegepant is Safe for Adults in India
Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
60
Planned (sponsor's estimate)
Start
Jul 24, 2026
Primary completion
Jan 4, 2028
Study completion Jan 4, 2028
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Jul 6, 2026
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, single-arm, open-label Phase 4 study evaluating the safety and tolerability of rimegepant 75 mg orally disintegrating tablet (ODT) for the acute treatment of migraine (with or without aura) in adult patients in India who have had an insufficient response, intolerance, or contraindication to triptans. It will enroll approximately 60 participants.
Conditions
- Acute Treatment of Migraine
Interventions
Rimegepant 75 mg ODTDrug
Rimegepant 75 mg ODT (1 tablet) PRN at the time of migraine attack
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of Treatment-emergent adverse events (TEAEs)Time frame: Up to 28 days
- Incidence of Serious adverse events (SAEs)Time frame: up to 28 days
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
Visakha Institute Medical Sciences
Visakhapatnam, Andhra Pradesh, India · Recruiting
Artemis Hospital
Gurugram, Haryana, India · Recruiting
BGS Global Institute of Medical Sciences
Bangalore, Karnataka, India · Recruiting
Mallikatta Neuro Centre
Mangalore, Karnataka, India · Recruiting
Chopda Medicare & Research Centre Pvt. Ltd: Magnum Heart Institute
Nashik, Maharashtra, India · Recruiting
Bhaktivedanta Hospital & Research Institute
Thane, Maharashtra, India · Recruiting
Bangur Institute of Neurosciences, IPGME&R - SSKM Hospital
Kolkata, West Bengal, India · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.